hemangiol
pierre fabre medicament - propranolola hidrohlorīds - hemangioma - beta blocking agents - hemangiol is indicated in the treatment of proliferating infantile haemangioma requiring systemic therapy: , life- or function-threatening haemangioma,, ulcerated haemangioma with pain and/or lack of response to simple wound care measures,, haemangioma with a risk of permanent scars or disfigurement. , it is to be initiated in infants aged 5 weeks to 5 months.
anaprilīns 10 mg tabletes
olainfarm, as, latvia - propranolola hidrohlorīds - tablete - 10 mg
anaprilīns 40 mg tabletes
olainfarm, as, latvia - propranolola hidrohlorīds - tablete - 40 mg
calvinia 10 mg mutē disperģējamās tabletes
gedeon richter plc., hungary - rizatriptāns - mutē disperģējamā tablete - 10 mg
topamax 50 mg apvalkotās tabletes
johnson & johnson, uab, lithuania - topiramāts - apvalkotā tablete - 50 mg
topamax 100 mg apvalkotās tabletes
johnson & johnson, uab, lithuania - topiramāts - apvalkotā tablete - 100 mg
topiramat orion 100 mg apvalkotās tabletes
orion corporation, finland - topiramāts - apvalkotā tablete - 100 mg
topamax 25 mg apvalkotās tabletes
johnson & johnson, uab, lithuania - topiramāts - apvalkotā tablete - 25 mg
topiramat orion 200 mg apvalkotās tabletes
orion corporation, finland - topiramāts - apvalkotā tablete - 200 mg
topiramat orion 50 mg apvalkotās tabletes
orion corporation, finland - topiramāts - apvalkotā tablete - 50 mg